1. In memoriam

   • Jeffrey Leppo
   • Pierluigi Pieri
   • Ignasi Carrió

   Obituary 10 November 2022 Pages: 237 - 238

   

2. Davis KW, Blankenbaker DG, and Bernard SA: Diagnostic Imaging. Musculoskeletal Non-traumatic Disease. Third Edition

   • Orlando Catalano
   • Luigi Mansi

   Book Review 28 November 2022 Pages: 239 - 239

3. Catalano Onofrio Antonio (Editor): Clinical PET/MRI

   • Luigi Mansi

   Book Review 29 November 2022 Pages: 240 - 241

4. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine

   • EANM Radiobiology Working Group:
   • Jean-Pierre Pouget
   • Michael Lassmann

   Editorial Open access 06 September 2022 Pages: 242 - 246

5. Cancer photodynamic therapy with chlorin e6-loaded, goat milk-derived extracellular vesicles: [¹⁸F]FDG lights up the way

   • Xiaoyan Li
   • Jessica C. Hsu
   • Weibo Cai

   Editorial 11 November 2022 Pages: 247 - 250

6. Stanford University from across the Atlantic Ocean: an Italian Medical Student research experience

   • Elisa Maria Ragaini

   Editorial 11 November 2022 Pages: 251 - 252

7. Positive opinion of the French National Authority for Health on the reimbursement of amyloid tracer (Flutemetamol)

   • Antoine Garnier-Crussard
   • Anthime Flaus

   Letter to the Editor 02 November 2022 Pages: 253 - 254

8. The role of radiographers in nuclear medicine; the link between patient and technology

   • Christina Baun
   • Rodrigo Garcia
   • Ana Geäo

   Letter to the Editor 09 November 2022 Pages: 255 - 256

9. Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [¹⁸F]-FDG datasets from a long axial FOV PET scanner

   • Hasan Sari
   • Lars Eriksson
   • Axel Rominger

   Original Article Open access 04 October 2022 Pages: 257 - 265

   

10. [¹¹C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue

    • Lihua Sun
    • Richard Aarnio
    • Anne Roivainen

    Original Article Open access 27 September 2022 Pages: 266 - 274

    

11. Enhanced antitumor immune responses via a new agent [¹³¹I]-labeled dual-target immunosuppressant

    • Chunjuan Jiang
    • Qiwei Tian
    • Shaoli Song

    Original Article Open access 15 October 2022 Pages: 275 - 286

    

12. Preclinical development of ZED8, an ⁸⁹Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy

    • Annie Ogasawara
    • James R. Kiefer
    • Simon-Peter Williams

    Original Article 22 October 2022 Pages: 287 - 301

    

13. High in-vivo stability in preclinical and first-in-human experiments with [¹⁸F]AlF-RESCA-MIRC213: a ¹⁸F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers

    • Xue Qin
    • Xiaoyi Guo
    • Zhi Yang

    Original Article 21 September 2022 Pages: 302 - 313

    

14. 9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice

    • Xiaofei Tian
    • Chentai Wang
    • Xin Zhang

    Original Article 27 September 2022 Pages: 314 - 327

    

15. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

    • Riad Salem
    • Siddharth A. Padia
    • Etienne Garin

    Guidelines Open access 17 September 2022 Pages: 328 - 343

16. Human biodistribution and radiation dosimetry of the demyelination tracer [¹⁸F]3F4AP

    • Pedro Brugarolas
    • Moses Q. Wilks
    • Georges El Fakhri

    Original Article Open access 05 October 2022 Pages: 344 - 351

    

17. Joint EANM/SNMMI guideline on radiomics in nuclear medicine

    • M. Hatt
    • A. K. Krizsan
    • D. Visvikis

    Guidelines Open access 03 November 2022 Pages: 352 - 375

    

18. Polar map-free 3D deep learning algorithm to predict obstructive coronary artery disease with myocardial perfusion CZT-SPECT

    • Chi-Lun Ko
    • Shau-Syuan Lin
    • Yen-Wen Wu

    Original Article 14 September 2022 Pages: 376 - 386

    

19. Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images

    • Robert J. H. Miller
    • Ananya Singh
    • Piotr J. Slomka

    Original Article 04 October 2022 Pages: 387 - 397

    

20. First-in-human evaluation of [¹⁸F]CETO: a novel tracer for adrenocortical tumours

    • Isabella Silins
    • Anders Sundin
    • Gunnar Antoni

    Original Article Open access 08 September 2022 Pages: 398 - 409

    

21. Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals

    • Jarith L. Ebenau
    • Denise Visser
    • Bart N. M. van Berckel

    Original Article Open access 08 September 2022 Pages: 410 - 422

    

22. Additive value of [¹⁸F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome

    • Sabrina Katzdobler
    • Alexander Nitschmann
    • for the German Imaging Initiative for Tauopathies (GII4T)

    Original Article Open access 14 September 2022 Pages: 423 - 434

    

23. Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players

    • Michael L. Alosco
    • Yi Su
    • for the DIAGNOSE C. T. E. Research Project

    Original Article Open access 24 September 2022 Pages: 435 - 452

    

24. Early detection of radiation-induced myocardial damage by [¹⁸F]AlF-NOTA-FAPI-04 PET/CT imaging

    • Yuchun Wei
    • Yuhong Sun
    • Jinming Yu

    Original Article 19 September 2022 Pages: 453 - 464

    

25. Molecular imaging of fibroblast activity in pressure overload heart failure using [⁶⁸ Ga]Ga-FAPI-04 PET/CT

    • Guokun Wang
    • Qinqin Yang
    • Suxuan Liu

    Original Article 29 September 2022 Pages: 465 - 474

    

26. ⁶⁸Ga-FAPI PET visualize heart failure: from mechanism to clinic

    • Wenyu Song
    • Xiao Zhang
    • Xiaoli Lan

    Original Article 21 October 2022 Pages: 475 - 485

    

27. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor

    • Gerben J. C. Zwezerijnen
    • Jakoba J. Eertink
    • Ronald Boellaard

    Original Article Open access 27 September 2022 Pages: 486 - 493

    

28. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue

    • Changjian Li
    • Jiahui Mi
    • Jie Tian

    Original Article 08 October 2022 Pages: 494 - 507

    

29. Chlorin e6-loaded goat milk-derived extracellular vesicles for Cerenkov luminescence-induced photodynamic therapy

    • Rong Guo
    • Dawei Jiang
    • Rui An

    Original Article 12 October 2022 Pages: 508 - 524

    

30. The role of quantitative tumor burden based on [⁶⁸ Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis

    • Luohai Chen
    • Nuerailaguli Jumai
    • Ning Zhang

    Original Article 01 October 2022 Pages: 525 - 534

    

31. Combination of pre-treatment dynamic [¹⁸F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma

    • Zhicong Li
    • Adrien Holzgreve
    • Lena Kaiser

    Original Article Open access 13 October 2022 Pages: 535 - 545

    

32. Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer

    • Clemens P. Spielvogel
    • Stefan Stoiber
    • Alexander R. Haug

    Original Article Open access 26 September 2022 Pages: 546 - 558

    

33. [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer

    • Arnaud Beddok
    • Fanny Orlhac
    • Irène Buvat

    Original Article 25 October 2022 Pages: 559 - 571

    

34. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

    • Alessandra Guido
    • Dajana Cuicchi
    • Alessio G. Morganti

    Original Article Open access 21 September 2022 Pages: 572 - 580

    

35. Estimation of post-therapeutic liver reserve capacity using ^99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors

    • Kana Yamazaki
    • Ryuichi Nishii
    • Tatsuya Higashi

    Original Article 04 October 2022 Pages: 581 - 592

    

36. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [⁶⁸ Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma

    • Liang Zhao
    • Yizhen Pang
    • Qin Lin

    Original Article 12 October 2022 Pages: 593 - 601

    

37. Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy

    • Liam Widjaja
    • Rudolf A. Werner
    • Thorsten Derlin

    Original Article Open access 22 September 2022 Pages: 602 - 612

    

38. Flare on [¹⁸F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients

    • Simona Malaspina
    • Otto Ettala
    • Jukka Kemppainen

    Original Article Open access 26 September 2022 Pages: 613 - 621

    

39. Ultra-low dose infection imaging of a newborn without sedation using long axial field-of-view PET/CT

    • N. D. van Rijsewijk
    • B. van Leer
    • A. W. J. M. Glaudemans

    Image of the Month Open access 27 September 2022 Pages: 622 - 623

    

40. [¹⁸F]FDG PET/CT snapshot of radioactive iodine–induced thyroid damage

    • Yaniv Yechiel
    • Zohar Keidar
    • Michal Weiler-Sagie

    Image of the Month 12 October 2022 Pages: 624 - 625

    

41. Multiple pseudotumors after ceramic-on-ceramic total hip arthroplasty revealed by [⁶⁸Ga]Ga-FAPI-04 PET/CT

    • Yiqun Wang
    • Ruimin Wang
    • Jiahe Tian

    Image of the Month 17 October 2022 Pages: 626 - 627

    

42. ⁶⁸Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer

    • Lena M. Unterrainer
    • Andrei Todica
    • Amanda Tufman

    Image of the Month Open access 18 October 2022 Pages: 628 - 629

    

43. Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

    • Rudi Dierckx
    • Ken Herrmann
    • Jolanta Kunikowska

    Correction 14 November 2022 Pages: 630 - 630

44. Correction to: Preclinical development of ZED8, an ⁸⁹Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy

    • Annie Ogasawara
    • James R. Kiefer
    • Simon‑Peter Williams

    Correction 25 November 2022 Pages: 631 - 631